Síndrome de compresión medular por cancer
Por:
Bautista-Hernández M.Y., Medina-Villaseñor E.A.
Publicada:
1 ene 2011
Resumen:
Malignant spinal cord compression (MSCC) is one of the most devastating neurologic complications after brain metastases; it is an oncologic emergency (independently of the type of tumor, extension into the epidural space or primary tumor extension) because MSCC can lead to irreversible loss of neurological function and certainly to a deterioration in the quality of life if not diagnosed early and no adequate treatment is initiated. The median overall survival of patients with MSCC ranges from 3-6 months; therefore, it is vitally important to recognize this entity. Radiation therapy in combination with corticosteroids remains the most commonly used treatment. Selectec patients benefit from surgical intervention. This article reviews the clinic and pathological characteristics, prognostic factors, and management of MSCC. New diagnostic and therapeutic techniques have been studied.
Filiaciones:
Bautista-Hernández M.Y.:
Médico Adscrito Unidad de Radioterapia, Servicio de Oncología, Hospital General de México, OD, México, DF, Mexico
Medina-Villaseñor E.A.:
Hospital Ángeles Metropolitano, Grupo Ángeles Servicios de Salud, Director Médico Centro Oncológico Betania, Mexico
|